- Open Access
Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline
Alzheimer's Research & Therapy volume 13, Article number: 25 (2021)
Correction to: Alz Res Ther (2020) 12:169
Following publication of the original article , the authors noticed that the published figures have errors which was occurred during processing of the figures in production team.
fonts are shifted (Figure 1)
colors are not displayed (Figure 2, open circles should be colored)
labelling is incorrect (Figure 4, "Afl" should be "Aß", Supplementary Figures "D Absorbance" should be "Δ absorbance" (Δ = delta))
Stockmann J, Verberk IMW, Timmesfeld N, et al. Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline. Alz Res Ther. 2020;12:169 https://doi.org/10.1186/s13195-020-00738-8.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Stockmann, J., Verberk, I.M.W., Timmesfeld, N. et al. Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline. Alz Res Therapy 13, 25 (2021). https://doi.org/10.1186/s13195-021-00770-2